The 19 analysts offering 12-month price forecasts for Novartis AG have a median target of 99.29, with a high estimate of 123.49 and a low estimate of 75.55. The median estimate represents a +19.14% increase from the last price of 83.34.
The current consensus among 24 polled investment analysts is to Buy stock in Novartis AG. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.64
Reporting Date Oct 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.